Covered recipient · General Payments record
JENNIFER L RANSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$811.96
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $329.61 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $190.76 | 18 |
| GlaxoSmithKline, LLC. | $44.93 | 3 |
| Otsuka America Pharmaceutical, Inc. | $31.45 | 2 |
| Astellas Pharma US Inc | $21.81 | 1 |
| Lilly USA, LLC | $20.97 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.81 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060699 | CMS |
| ABBVIE INC. | $10.11 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060701 | CMS |
| ABBVIE INC. | $4.60 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060703 | CMS |
| ABBVIE INC. | $4.66 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060705 | CMS |
| ABBVIE INC. | $8.64 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060707 | CMS |
| ABBVIE INC. | $22.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060709 | CMS |
| ABBVIE INC. | $22.03 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060711 | CMS |
| ABBVIE INC. | $6.74 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060713 | CMS |
| ABBVIE INC. | $14.53 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060715 | CMS |
| ABBVIE INC. | $6.98 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060717 | CMS |
| ABBVIE INC. | $3.85 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060719 | CMS |
| ABBVIE INC. | $11.79 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060721 | CMS |
| ABBVIE INC. | $4.32 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060723 | CMS |
| ABBVIE INC. | $6.75 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060725 | CMS |
| ABBVIE INC. | $25.88 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060727 | CMS |
| ABBVIE INC. | $2.24 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060729 | CMS |
| ABBVIE INC. | $8.24 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060731 | CMS |
| ABBVIE INC. | $10.75 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108060733 | CMS |
| Astellas Pharma US Inc | $21.81 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139502396 | CMS |
| GlaxoSmithKline, LLC. | $14.83 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115903511 | CMS |
| GlaxoSmithKline, LLC. | $15.65 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116257013 | CMS |
| GlaxoSmithKline, LLC. | $14.45 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116106662 | CMS |
| Lilly USA, LLC | $20.97 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135656291 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.61 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119168474 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.84 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119168476 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.69 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144628576 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.